Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Number of holders
-
235
-
Total 13F shares, excl. options
-
155,850,778
-
Shares change
-
-3,576,650
-
Total reported value, excl. options
-
$2,963,320,040
-
Value change
-
-$77,138,233
-
Put/Call ratio
-
21.81%
-
Number of buys
-
121
-
Number of sells
-
-112
-
Price
-
$19.09
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2021
299 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q4 2021.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155,850,778 shares
of 334,352,960 outstanding shares and own 46.61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (12,197,787 shares), PERCEPTIVE ADVISORS LLC (10,127,941 shares), WELLINGTON MANAGEMENT GROUP LLP (9,584,082 shares), Avoro Capital Advisors LLC (8,675,000 shares), BlackRock Inc. (7,408,505 shares), ARK Investment Management LLC (7,201,518 shares), ORBIMED ADVISORS LLC (6,337,700 shares), FARALLON CAPITAL MANAGEMENT LLC (6,061,973 shares), FRANKLIN RESOURCES INC (5,797,631 shares), and STATE STREET CORP (5,093,682 shares).
This table shows the top 235 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.